Posted on October 01, 2012

Science Board to the Food and Drug Administration

• Outstanding Junior Investigator Presentation: Jie Zheng  (PDF - 1.1MB)
• FDASIA Legislation - Nanotechnology Section  (PDF - 52KB)
• FDA's Nanotechnology Web Page  (PDF - 187KB)
• Briefing Materials for the Oct. 3, 2012 Meeting of the Science Board to the FDA
• 2012 Meeting Materials, Science Board to the Food and Drug Administration
• Salmonella’s Continued Assault on the Food Supply: Fighting Back With the Old, the New, and the Unexpected  (PDF - 3.5MB)
• Slides for the October 3, 2012 Meeting of the Science Board to the FDA
• NCTR Genomics Projects  (PDF - 1.1MB)
• Draft Agenda for the Oct. 3, 2012 Meeting of the Science Board to the FDA  (PDF - 45KB)

Ophthalmic Devices Panel

• Presentation: Second Sight  (PDF - 3.5MB)
• 2012 Meeting Materials of the Ophthalmic Devices Panel

Science Board to the Food and Drug Administration

• Excellence in Analytical Science Presentation: Mikhail V. Ovanesov  (PDF - 931KB)
• Outstanding Support Scientist: Edward L. E. Jester  (PDF - 1.5MB)
• Genomics Activities: Center for Biologics Evaluation and Research  (PDF - 121KB)
• Excellence in Review Science Presentation  (PDF - 147KB)
• Excellence in Laboratory Science Presentation  (PDF - 1.6MB)
• Meeting Roster for the Oct. 3, 2012 Meeting of the Science Board to the FDA  (PDF - 28KB)

Posted on September 28, 2012

Orthopaedic and Rehabilitation Devices Panel

• Presentation: FDA  (PDF - 1.7MB)
• Presentation: Cervical Spine Research Society  (PDF - 189KB)
• Presentation: North American Spine Society  (PDF - 665KB)
• Presentation: American Academy of Orthopadic  (PDF - 953KB)
• Scoliosis Research Society Presentation  (PDF - 2.8MB)
• OSMA Presentation  (PDF - 7MB)
• 2012 Meeting Materials of the Orthopaedic and Rehabilitation Devices Panel

Posted on September 27, 2012

Risk Communication Advisory Committee

• June 29, 2012: Presentations

Posted on September 26, 2012

Dermatologic and Ophthalmic Drugs Advisory Committee

• Transcript for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (PM Session)  (PDF - 927KB)
• Transcript for the July 26, 2012 Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (AM Session)  (PDF - 1.1MB)
• 2012 Meeting Materials, Dermatologic and Ophthalmic Drugs Advisory Committee

Advisory Committee Calendar

• November 9, 2012: Nonprescription Drugs Advisory Committee Meeting Announcement

Anti-Infective Drugs Advisory Committee

• 2012 Meeting Materials, Anti-Infective Drugs Advisory Committee

Advisory Committee Calendar

• November 28, 2012: Anti-Infective Drugs Advisory Committee Meeting Announcement

Ophthalmic Devices Panel

• Panel Roster  (PDF - 13KB)

Orthopaedic and Rehabilitation Devices Panel

• 24-Hour Summary  (PDF - 83KB)

Posted on September 25, 2012

Advisory Committee Calendar

• October 23-24, 2012: Science Advisory Board to the National Center for Toxicological Research Meeting Announcement

Ophthalmic Devices Panel

• Sponsor Executive Summary  (PDF - 2.1MB)
• FDA Executive Summary  (PDF - 5.3MB)
• Panel Questions  (PDF - 44KB)
• Meeting Agenda  (PDF - 35KB)

Posted on September 24, 2012

Oncologic Drugs Advisory Committee

• Transcript for the July 25, 2012 Meeting of the Oncologic Drugs Advisory Committee  (PDF - 382KB)
• 2012 Meeting Materials, Oncologic Drugs Advisory Committee

Cardiovascular and Renal Drugs Advisory Committee

• Final Questions for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (AM Session)  (PDF - 15KB)
• 2012 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee

Pharmaceutical Science and Clinical Pharmacology Advisory Committee

• Curriculum Vitae: Elizabeth Topp  (PDF - 408KB)
• Curriculum Vitae: Peter Honig  (PDF - 246KB)
• Curriculum Vitae: Arthur F. Harralson  (PDF - 229KB)
• Curriculum Vitae: Joseph Kosler  (PDF - 244KB)
• Curriculum Vitae: Edwin Hemwall  (PDF - 230KB)
• Curriculum Vitae: Jack Cook  (PDF - 20KB)

Cardiovascular and Renal Drugs Advisory Committee

• Webcast Information for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee  (PDF - 29KB)
• Slides for the September 13, 2012 Meeting of the Cardiovascular and Renal Drugs Advisory Committee